HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


L’Oreal Picks Up CeraVe Skin Care Via $1.3bn Deal With Valeant

This article was originally published in The Rose Sheet

Executive Summary

The CeraVe, AcneFree and Ambi skin-care lines will change hands from Valeant Pharmaceuticals to L’Oreal under a deal announced Jan. 10, beefing up the latter’s dermatologist-aligned Active Cosmetics division.


Related Content

L'Oreal Vows Consumer Division Excitement; 'Mass Will Be Back,' CEO Says
L’Oréal Benefits From 'Skin-Care Comeback,' With Mass Makeup Slowing
Biopharma Quarterly Deal-Making Statistics, Q1 2017
L’Oreal ‘Surfing’ Makeup Wave To Projected Strong Finish For FY 2016
In Brief: L’Oreal Acquires IT Cosmetics, Provides Microbeads Update; More





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts